Cowen and Company’s Nuvation Bio NUVB Stock Holding History

Cowen and Company’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-359,375	Closed	-$3.06M	–	701
2021 Q4	$3.06M	Hold	359,375	–	–	0.28%	74
2021 Q3	$3.57M	Hold	359,375	–	–	0.17%	59
2021 Q2	$3.35M	Sell	359,375 -48,750	-12%	-$556K	0.17%	50
2021 Q1	$4.26M	Buy	408,125 +378,125	+1,260%	+$4.23M	0.29%	33
2020 Q4	$351K	Sell	30,000 -11,811	-28%	-$123K	0.03%	132
2020 Q3	$468K	Buy	+41,811	New	+$452K	0.08%	150

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Cowen and Company's NUVB Position: Q1 2022 in Review

Cowen and Company sold out of Nuvation Bio (NUVB) in Q1 2022, closing a stake of 359,375 shares — an estimated $3.06M sold.

Cowen and Company first reported a position in NUVB in Q3 2020 and held it in 6 quarters. The position peaked at $4.26M in Q1 2021. 117 funds tracked by Wall St. Rank hold NUVB as of Q1 2022.

Cowen and Company reported no remaining Nuvation Bio position as of Q1 2022 after selling out during the quarter.
Cowen and Company sold 359,375 Nuvation Bio shares in Q1 2022, an estimated $3.06M.
Cowen and Company first reported a position in Nuvation Bio in Q3 2020 and held it in 6 quarters.
Cowen and Company's Nuvation Bio position peaked at $4.26M in Q1 2021.
117 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2022.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.